Fed. Circ. Affirms PTAB Ruling Axing Glucose-Testing Patent
By Kelly Knaub ( January 20, 2016, 4:56 PM EST) -- The Federal Circuit on Wednesday affirmed a Patent Trial and Appeal Board decision in an America Invents Act inter partes review that Johnson & Johnson subsidiary LifeScan Scotland Ltd.'s patent on testing the level of glucose in the blood is invalid as obvious....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.